Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2015. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3046441016 | Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | en | Definition | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
3046754012 | Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterized by extensive necrosis and detachment of the epidermis. | en | Definition | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
3046331018 | Stevens Johnson syndrome AND toxic epidermal necrolysis overlap | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
3046358013 | Stevens Johnson syndrome AND toxic epidermal necrolysis overlap (disorder) | en | Fully specified name | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
7847941000241113 | syndrome de chevauchement SSJ/NET (syndrome de Stevens-Johnson et nécrolyse épidermique toxique) | fr | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT Switzerland NRC maintained Module |
7847951000241111 | syndrome de chevauchement entre syndrome de Stevens-Johnson et nécrolyse épidermique toxique | fr | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT Switzerland NRC maintained Module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Is a | A limited form of Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum characterised by destruction and detachment of the skin epithelium, involving less than 10% of the body surface area, and mucous membranes. Onset usually occurs 4-28 days after administration of the causal medication and is most frequently associated with anticonvulsants, antibacterial sulfonamides, allopurinol, nevirapine, and oxicams (non-steroidal anti-inflammatory drugs), but many other medications have also been implicated. The disease is not induced by medication in 15% of cases. Histology is characterised by an epidermal necrolysis. Multiple disabling long-term sequelae (especially cutaneous, ocular and psychological) are frequent. | false | Inferred relationship | Some | ||
Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Finding site | Oral mucous membrane structure | false | Inferred relationship | Some | ||
Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Due to | A pathological immune process generally directed towards a foreign antigen, which results in tissue injury, which is usually transient. It is the realization of the allergic disposition. It is most often applied to type I hypersensitivity but other hypersensitivity types especially type IV (e.g. allergic contact dermatitis) may be involved. | false | Inferred relationship | Some | ||
Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Associated morphology | Erythema | false | Inferred relationship | Some | 3 | |
Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Finding site | Skin structure | false | Inferred relationship | Some | 3 | |
Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Is a | Lyell's toxic epidermal necrolysis, subepidermal type | false | Inferred relationship | Some | ||
Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Pathological process (attribute) | An immune or non-immune mediated pathological process that represents the underlying mechanism of hypersensitivity conditions. | true | Inferred relationship | Some | 1 | |
Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Pathological process (attribute) | An immune or non-immune mediated pathological process that represents the underlying mechanism of hypersensitivity conditions. | true | Inferred relationship | Some | 2 | |
Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Associated morphology | Morbilliform rash | false | Inferred relationship | Some | 4 | |
Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Associated morphology | Exfoliative erythema | false | Inferred relationship | Some | 4 | |
Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Finding site | Skin structure | false | Inferred relationship | Some | 4 | |
Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Pathological process (attribute) | An immune or non-immune mediated pathological process that represents the underlying mechanism of hypersensitivity conditions. | false | Inferred relationship | Some | 5 | |
Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Associated morphology | Necrosis | true | Inferred relationship | Some | 2 | |
Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Finding site | Epidermis structure | true | Inferred relationship | Some | 2 | |
Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Finding site | Skin structure | true | Inferred relationship | Some | 1 | |
Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Associated morphology | Ulcerative inflammation | false | Inferred relationship | Some | 5 | |
Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Finding site | Oral mucous membrane structure | false | Inferred relationship | Some | 5 | |
Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Associated morphology | Erythema | true | Inferred relationship | Some | 1 | |
Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Clinical course | Sudden onset AND/OR short duration (qualifier value) | true | Inferred relationship | Some | 4 | |
Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Is a | The disposition to develop an allergic or pseudoallergic reaction, the reaction itself or its consequences. | true | Inferred relationship | Some | ||
Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Finding site | Structure of skin and/or mucous membrane (body structure) | true | Inferred relationship | Some | 3 | |
Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Associated morphology | Separation | true | Inferred relationship | Some | 3 | |
Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Is a | A rare toxic dermatosis with clinical and histological features characterized by the destruction and detachment of the skin epithelium and mucous membranes. | true | Inferred relationship | Some | ||
Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Pathological process (attribute) | An immune or non-immune mediated pathological process that represents the underlying mechanism of hypersensitivity conditions. | true | Inferred relationship | Some | 3 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Stevens-Johnson and toxic epidermal necrolysis overlap syndrome caused by drug (disorder) | Is a | True | Severe mucocutaneous reactions; skin detachment of 10 to 30 percent of body surface area most commonly triggered by medications, characterised by extensive necrosis and detachment of the epidermis. | Inferred relationship | Some |
Reference Sets
Description inactivation indicator reference set